TNX-102 SL Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TNX-102 SL Tablets, covering 2024-12-11 to 2024-12-11. Get the full timeline:
Most recent: Clinical Trial Update: A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients [Phase 3]